Selected research
Industry Growth & Trends
Global Integrated Precision Diagnosis and Treatment Solution Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Integrated Precision Diagnosis and Treatment Solution market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Integrated Precision Diagnosis and Treatment Solution is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Integrated Precision Diagnosis and Treatment Solution is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Integrated Precision Diagnosis and Treatment Solution is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Integrated Precision Diagnosis and Treatment Solution market include Illumina, QIAGEN, Caris Life Sciences, Foundation Medicine, Guardant Health, NeoGenomics, Myriad Genetics, Thermo Fisher Scientific and Roche Holding AG, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Integrated Precision Diagnosis and Treatment Solution market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Integrated Precision Diagnosis and Treatment Solution market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Integrated Precision Diagnosis and Treatment Solution market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Integrated Precision Diagnosis and Treatment Solution.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Integrated Precision Diagnosis and Treatment Solution market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Integrated Precision Diagnosis and Treatment Solution Market by Company
Illumina
QIAGEN
Caris Life Sciences
Foundation Medicine
Guardant Health
NeoGenomics
Myriad Genetics
Thermo Fisher Scientific
Roche Holding AG
Abbott Laboratories
GE HealthCare
Tempus Labs
Personalis
Genome Medical
Endeavor Biomedicines
Integrated Precision Diagnosis and Treatment Solution Segment by Type
Genomics
Proteomics
Metabolomics
Radiomics
Integrated Precision Diagnosis and Treatment Solution Segment by Application
Medical Institutions
Research and Academic Institutions
Integrated Precision Diagnosis and Treatment Solution Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Integrated Precision Diagnosis and Treatment Solution market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Integrated Precision Diagnosis and Treatment Solution and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Integrated Precision Diagnosis and Treatment Solution.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Integrated Precision Diagnosis and Treatment Solution companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Genomics
- Proteomics
- Metabolomics
- Radiomics
Applications
- Medical Institutions
- Research and Academic Institutions
Companies covered
- Illumina
- QIAGEN
- Caris Life Sciences
- Foundation Medicine
- Guardant Health
- NeoGenomics
- Myriad Genetics
- Thermo Fisher Scientific
- Roche Holding AG
- Abbott Laboratories
- GE HealthCare
- Tempus Labs
- Personalis
- Genome Medical
- Endeavor Biomedicines
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Integrated Precision Diagnosis and Treatment Solution Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Integrated Precision Diagnosis and Treatment Solution Market Size by Region (2021-2032)
- 1.4.1 Global Integrated Precision Diagnosis and Treatment Solution Market Size by Region (2021-2026)
- 1.4.2 Global Integrated Precision Diagnosis and Treatment Solution Market Size by Region (2027-2032)
- 1.5 Key Regions Integrated Precision Diagnosis and Treatment Solution Market Size (2021-2032)
- 1.5.1 North America Integrated Precision Diagnosis and Treatment Solution Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Integrated Precision Diagnosis and Treatment Solution Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Integrated Precision Diagnosis and Treatment Solution Market Size Growth Rate (2021-2032)
- 1.5.4 South America Integrated Precision Diagnosis and Treatment Solution Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Integrated Precision Diagnosis and Treatment Solution Market Size Growth Rate (2021-2032)
2 Integrated Precision Diagnosis and Treatment Solution Market by Type
- 2.1 Type Introduction
- 2.1.1 Genomics
- 2.1.2 Proteomics
- 2.1.3 Metabolomics
- 2.1.4 Radiomics
- 2.2 Global Integrated Precision Diagnosis and Treatment Solution Market Size by Type
- 2.2.1 Global Integrated Precision Diagnosis and Treatment Solution Market Size Overview by Type (2021-2032)
- 2.2.2 Global Integrated Precision Diagnosis and Treatment Solution Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Integrated Precision Diagnosis and Treatment Solution Market Size Forecasted by Type (2027-2032)
- 2.3 Global Integrated Precision Diagnosis and Treatment Solution Market Size by Regions
- 2.3.1 North America Integrated Precision Diagnosis and Treatment Solution Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Integrated Precision Diagnosis and Treatment Solution Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Integrated Precision Diagnosis and Treatment Solution Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Integrated Precision Diagnosis and Treatment Solution Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Integrated Precision Diagnosis and Treatment Solution Market Size Breakdown by Type (2021-2026)
3 Integrated Precision Diagnosis and Treatment Solution Market by Application
- 3.1 Type Introduction
- 3.1.1 Medical Institutions
- 3.1.2 Research and Academic Institutions
- 3.2 Global Integrated Precision Diagnosis and Treatment Solution Market Size by Application
- 3.2.1 Global Integrated Precision Diagnosis and Treatment Solution Market Size Overview by Application (2021-2032)
- 3.2.2 Global Integrated Precision Diagnosis and Treatment Solution Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Integrated Precision Diagnosis and Treatment Solution Market Size Forecasted by Application (2027-2032)
- 3.3 Global Integrated Precision Diagnosis and Treatment Solution Market Size by Regions
- 3.3.1 North America Integrated Precision Diagnosis and Treatment Solution Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Integrated Precision Diagnosis and Treatment Solution Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Integrated Precision Diagnosis and Treatment Solution Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Integrated Precision Diagnosis and Treatment Solution Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Integrated Precision Diagnosis and Treatment Solution Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Integrated Precision Diagnosis and Treatment Solution Industry Trends
- 4.2 Integrated Precision Diagnosis and Treatment Solution Industry Drivers
- 4.3 Integrated Precision Diagnosis and Treatment Solution Industry Opportunities and Challenges
- 4.4 Integrated Precision Diagnosis and Treatment Solution Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Integrated Precision Diagnosis and Treatment Solution Revenue (2021-2026)
- 5.2 Global Integrated Precision Diagnosis and Treatment Solution Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Integrated Precision Diagnosis and Treatment Solution Key Company Headquarters & Area Served
- 5.4 Global Integrated Precision Diagnosis and Treatment Solution Company, Product Type & Application
- 5.5 Global Integrated Precision Diagnosis and Treatment Solution Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Integrated Precision Diagnosis and Treatment Solution Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Integrated Precision Diagnosis and Treatment Solution Players Market Share by Revenue in 2025
- 5.6.3 2025 Integrated Precision Diagnosis and Treatment Solution Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Illumina
- 6.1.1 Illumina Company Information
- 6.1.2 Illumina Business Overview
- 6.1.3 Illumina Integrated Precision Diagnosis and Treatment Solution Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Illumina Integrated Precision Diagnosis and Treatment Solution Product Portfolio
- 6.1.5 Illumina Recent Developments
- 6.2 QIAGEN
- 6.2.1 QIAGEN Company Information
- 6.2.2 QIAGEN Business Overview
- 6.2.3 QIAGEN Integrated Precision Diagnosis and Treatment Solution Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 QIAGEN Integrated Precision Diagnosis and Treatment Solution Product Portfolio
- 6.2.5 QIAGEN Recent Developments
- 6.3 Caris Life Sciences
- 6.3.1 Caris Life Sciences Company Information
- 6.3.2 Caris Life Sciences Business Overview
- 6.3.3 Caris Life Sciences Integrated Precision Diagnosis and Treatment Solution Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Caris Life Sciences Integrated Precision Diagnosis and Treatment Solution Product Portfolio
- 6.3.5 Caris Life Sciences Recent Developments
- 6.4 Foundation Medicine
- 6.4.1 Foundation Medicine Company Information
- 6.4.2 Foundation Medicine Business Overview
- 6.4.3 Foundation Medicine Integrated Precision Diagnosis and Treatment Solution Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Foundation Medicine Integrated Precision Diagnosis and Treatment Solution Product Portfolio
- 6.4.5 Foundation Medicine Recent Developments
- 6.5 Guardant Health
- 6.5.1 Guardant Health Company Information
- 6.5.2 Guardant Health Business Overview
- 6.5.3 Guardant Health Integrated Precision Diagnosis and Treatment Solution Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Guardant Health Integrated Precision Diagnosis and Treatment Solution Product Portfolio
- 6.5.5 Guardant Health Recent Developments
- 6.6 NeoGenomics
- 6.6.1 NeoGenomics Company Information
- 6.6.2 NeoGenomics Business Overview
- 6.6.3 NeoGenomics Integrated Precision Diagnosis and Treatment Solution Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 NeoGenomics Integrated Precision Diagnosis and Treatment Solution Product Portfolio
- 6.6.5 NeoGenomics Recent Developments
- 6.7 Myriad Genetics
- 6.7.1 Myriad Genetics Company Information
- 6.7.2 Myriad Genetics Business Overview
- 6.7.3 Myriad Genetics Integrated Precision Diagnosis and Treatment Solution Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 Myriad Genetics Integrated Precision Diagnosis and Treatment Solution Product Portfolio
- 6.7.5 Myriad Genetics Recent Developments
- 6.8 Thermo Fisher Scientific
- 6.8.1 Thermo Fisher Scientific Company Information
- 6.8.2 Thermo Fisher Scientific Business Overview
- 6.8.3 Thermo Fisher Scientific Integrated Precision Diagnosis and Treatment Solution Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Thermo Fisher Scientific Integrated Precision Diagnosis and Treatment Solution Product Portfolio
- 6.8.5 Thermo Fisher Scientific Recent Developments
- 6.9 Roche Holding AG
- 6.9.1 Roche Holding AG Company Information
- 6.9.2 Roche Holding AG Business Overview
- 6.9.3 Roche Holding AG Integrated Precision Diagnosis and Treatment Solution Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 Roche Holding AG Integrated Precision Diagnosis and Treatment Solution Product Portfolio
- 6.9.5 Roche Holding AG Recent Developments
- 6.10 Abbott Laboratories
- 6.10.1 Abbott Laboratories Company Information
- 6.10.2 Abbott Laboratories Business Overview
- 6.10.3 Abbott Laboratories Integrated Precision Diagnosis and Treatment Solution Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 Abbott Laboratories Integrated Precision Diagnosis and Treatment Solution Product Portfolio
- 6.10.5 Abbott Laboratories Recent Developments
- 6.11 GE HealthCare
- 6.11.1 GE HealthCare Company Information
- 6.11.2 GE HealthCare Business Overview
- 6.11.3 GE HealthCare Integrated Precision Diagnosis and Treatment Solution Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 GE HealthCare Integrated Precision Diagnosis and Treatment Solution Product Portfolio
- 6.11.5 GE HealthCare Recent Developments
- 6.12 Tempus Labs
- 6.12.1 Tempus Labs Company Information
- 6.12.2 Tempus Labs Business Overview
- 6.12.3 Tempus Labs Integrated Precision Diagnosis and Treatment Solution Revenue, Global Share and Gross Margin (2021-2026)
- 6.12.4 Tempus Labs Integrated Precision Diagnosis and Treatment Solution Product Portfolio
- 6.12.5 Tempus Labs Recent Developments
- 6.13 Personalis
- 6.13.1 Personalis Company Information
- 6.13.2 Personalis Business Overview
- 6.13.3 Personalis Integrated Precision Diagnosis and Treatment Solution Revenue, Global Share and Gross Margin (2021-2026)
- 6.13.4 Personalis Integrated Precision Diagnosis and Treatment Solution Product Portfolio
- 6.13.5 Personalis Recent Developments
- 6.14 Genome Medical
- 6.14.1 Genome Medical Company Information
- 6.14.2 Genome Medical Business Overview
- 6.14.3 Genome Medical Integrated Precision Diagnosis and Treatment Solution Revenue, Global Share and Gross Margin (2021-2026)
- 6.14.4 Genome Medical Integrated Precision Diagnosis and Treatment Solution Product Portfolio
- 6.14.5 Genome Medical Recent Developments
- 6.15 Endeavor Biomedicines
- 6.15.1 Endeavor Biomedicines Company Information
- 6.15.2 Endeavor Biomedicines Business Overview
- 6.15.3 Endeavor Biomedicines Integrated Precision Diagnosis and Treatment Solution Revenue, Global Share and Gross Margin (2021-2026)
- 6.15.4 Endeavor Biomedicines Integrated Precision Diagnosis and Treatment Solution Product Portfolio
- 6.15.5 Endeavor Biomedicines Recent Developments
7 North America
- 7.1 North America Integrated Precision Diagnosis and Treatment Solution Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Integrated Precision Diagnosis and Treatment Solution Market Size by Country (2021-2026)
- 7.3 North America Integrated Precision Diagnosis and Treatment Solution Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Integrated Precision Diagnosis and Treatment Solution Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Integrated Precision Diagnosis and Treatment Solution Market Size by Country (2021-2026)
- 8.3 Europe Integrated Precision Diagnosis and Treatment Solution Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Integrated Precision Diagnosis and Treatment Solution Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Integrated Precision Diagnosis and Treatment Solution Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Integrated Precision Diagnosis and Treatment Solution Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Integrated Precision Diagnosis and Treatment Solution Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Integrated Precision Diagnosis and Treatment Solution Market Size by Country (2021-2026)
- 10.3 South America Integrated Precision Diagnosis and Treatment Solution Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Integrated Precision Diagnosis and Treatment Solution Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Integrated Precision Diagnosis and Treatment Solution Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Integrated Precision Diagnosis and Treatment Solution Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst